According to the results of the period from May 2016 to April 2017, the volume of the Russian Federation’s market of drugs for the treatment of varicose veins of the lower extremities amounted to 15.5 billion rubles in value4 and 49.3 million packages in volume. The main sales channel is retail, accounting for 98% of all the sales in rubles and in packages. In the last observable period, the market was growing more actively than previously, finally showing positive trends in the growth of sales by volume (+ 2%), and the growth of sales in value that more than doubled compared to the previous period (+ 14%) (Figure 2).
1) In the retail segment, the volume of sales from pharmacies in the final consumers’ prices (sell-out) was taken into account.
According to the results of the period from May 2016 to April 2017, the volume of the Russian Federation’s market of drugs for the treatment of varicose veins of the lower extremities amounted to 15.5 billion rubles in value4 and 49.3 million packages in volume. The main sales channel is retail, accounting for 98% of all the sales in rubles and in packages. In the last observable period, the market was growing more actively than previously, finally showing positive trends in the growth of sales by volume (+ 2%), and the growth of sales in value that more than doubled compared to the previous period (+ 14%) (Figure 2).
1) In the retail segment, the volume of sales from pharmacies in the final consumers’ prices (sell-out) was taken into account.